Kahle KT, Barnett SM, Sassower KC, et al. Decreased seizure activity in a human neonate treated with bumetanide, an inhibitor of the Na(+)-K(+)-2Cl(-) cotransporter NKCC1. J Child Neurol. 2009;24:572-576.
2.
Kahle KT, Staley KJThe bumetanide-sensitive Na-K-2Cl cotransporter NKCC1 as a potential target of a novel mechanism-based treatment strategy for neonatal seizures. Neurosurg Focus. 2008; 25:E22.
3.
Dzhala VI, Talos DM, Sdrulla DA, et al. NKCC1 transporter facilitates seizures in the developing brain . Nat Med. 2005;11: 1205-1213.
4.
Dzhala VI, Brumback AC, Staley KJBumetanide enhances phenobarbital efficacy in a neonatal seizure model. Ann Neurol. 2008;63:222-235.
5.
Nardou R., Ben-Ari Y., Khalilov I.Bumetanide, an NKCC1 antagonist, does not prevent formation of epileptogenic focus but blocks epileptic focus seizures in immature rat hippocampus. J Neurophysiol. 2009;101:2878-2888.
6.
Mazarati A., Shin D., Sankar R.Bumetanide inhibits rapid kindling in neonatal rats. Epilepsia . 2009;50:2117-2122.
7.
Dzhala VI, Kuchibhotla KV, Glykys JC, et al. Progressive NKCC1-dependent neuronal chloride accumulation during neonatal seizures. J Neurosci. 2010;30:11745-11761.
8.
Wahab A., Albus K., Heinemann U.Age- and region-specific effects of anticonvulsants and bumetanide on 4-aminopyridine-induced seizure-like events in immature rat hippocampal-entorhinal cortex slices. Epilepsia. 2011;52:94-103.
9.
Sullivan JE, Witte MK, Yamashita TS, et al. Pharmacokinetics of bumetanide in critically ill infants. Clin Pharmacol Ther. 1996; 60:405-413.
10.
Lopez-Samblas AM, Adams JA, Goldberg RN, et al. The pharmacokinetics of bumetanide in the newborn infant. Biol Neonate. 1997;72:265-272.
11.
Lemonnier E. , Ben-Ari Y.The diuretic bumetanide decreases autistic behaviour in five infants treated during 3 months with no side effects. Acta Paediatr. 2010;99: 1885-1888.
12.
Ben-Ari Y.Excitatory actions of GABA during development: the nature of the nurture. Nat Rev Neurosci. 2002;3:728-739.
13.
Wang DD, Kriegstein ARBlocking early GABA depolarization with bumetanide results in permanent alterations in cortical circuits and sensorimotor gating deficits [published online ahead of print July 19, 2010]. Cereb Cortex.
14.
Edwards DA, Shah HP, Cao W., et al. Bumetanide alleviates epileptogenic and neurotoxic effects of sevoflurane in neonatal rat brain. Anesthesiology. 2010;112:567-575.
15.
Brandt C., Nozadze M., Heuchert N., et al. Disease-modifying effects of phenobarbital and the NKCC1 inhibitor bumetanide in the pilocarpine model of temporal lobe epilepsy. J Neurosci. 2010;30:8602-8612.
16.
Bittigau P. , Sifringer M., Genz K., et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A. 2002;99:15089-15094.
17.
Ge S., Goh EL, Sailor KA, et al. GABA regulates synaptic integration of newly generated neurons in the adult brain. Nature. 2006; 439:589-593.
18.
Cancedda L. , Fiumelli H., Chen K., et al. Excitatory GABA action is essential for morphological maturation of cortical neurons in vivo. J Neurosci. 2007;27:5224-5235.
19.
Wirrell EC, Armstrong EA, Osman LD, et al. Prolonged seizures exacerbate perinatal hypoxic-ischemic brain damage. Pediatr Res. 2001;50:445-454.
20.
Auvin S., Shin D., Mazarati A., et al. Inflammation exacerbates seizure-induced injury in the immature brain. Epilepsia. 2007; 48(suppl 5):27-34.
21.
Farwell JR, Lee YJ, Hirtz DG, Sulzbacher SI, et al. Phenobarbital for febrile seizures-effects on intelligence and on seizure recurrence. N Engl J Med. 1990;322:364-369.
22.
Reinisch JM , Sanders SA, Mortensen EL, et al. In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA. 1995;274:1518-1525.
